​

Funding Round

Series B - Gameto

Series B - Gameto

Investment Firm

Overview

Gameto is a biotechnology company developing therapeutics of the female reproductive system using cell engineering.

Announced Date

May 29, 2024

Closed on Date

May 29, 2024

Funding Type

Series B

Highlights

Location

New York, New York, United States, North America

Social

Investor Lead

Two Sigma Ventures

Two Sigma Ventures

Two Sigma Ventures is a early_stage_venture and seed firm.

RA Capital Management

RA Capital Management

RA Capital Management is a convertible_note and debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Participant Investors

19

Investor Name
Participant InvestorInsight Partners
Participant InvestorAnne Wojcicki
Participant InvestorBold Capital Partners
Participant InvestorJack Abraham
Participant InvestorDan Rose

Round Details and Background

Gameto raised $33000000 on 2024-05-29 in Series B

Gameto is a biotechnology company developing therapeutics of the female reproductive system using cell engineering.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 01, 2020
Seed Round - Gameto
5-3.0M
Sep 14, 2022
Venture Round - Gameto
9-17.0M
Apr 02, 2021
Seed Round - Gameto
3-undefined
May 29, 2024
Series B - Gameto
21-33.0M

Recent Activity

There is no recent news or activity for this profile.